Literature DB >> 32797278

Systemic lupus erythematosus complicated with Castleman disease: a case-based review.

Fatma Gül Demirkan1, Sümeyra Doğan2, Ayşe Kalyoncu Uçar2, Hafize Emine Sönmez1, Nuray Aktay Ayaz3.   

Abstract

Systemic lupus erythematosus (SLE) is a complex, chronic, multi-systemic autoimmune disease, characterized by miscellaneous clinical findings. Castleman disease (CD) is a rare lymphoproliferative disorder that may present with systemic symptoms. Herein, a SLE case complicated with CD is reported by comparing her clinical findings with previously reported patients. We reviewed the literature regarding cases of "Castleman disease" and "Systemic lupus erythematosus" by searching medical journal databases in MEDLINE, EMBASE, Scopus, and Web of Science. A case of a 16-year-old girl with SLE who had intraabdominal lymphadenopathy detected both by ultrasonography and abdominal magnetic resonance imaging is presented. The excision of the lymph node was performed by pediatric surgeons. Histopathological examination was compatible with CD. Hydroxychloroquine and steroid treatments were started after the operation. She achieved remission in 3 months. In the literature research, we found 10 articles describing 17 patients. To our best of knowledge, the presented case was the third pediatric case in the literature with SLE and coexistent CD. This case report and literature review suggests that CD should be considered while evaluating and following patients with autoimmune diseases.

Entities:  

Keywords:  Castleman disease; Lymphadenopathy; Pathology; Systemic lupus erythematosus

Year:  2020        PMID: 32797278     DOI: 10.1007/s00296-020-04684-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

1.  Systemic lupus erythematosus and Castleman's disease.

Authors:  S Suwannaroj; S L Elkins; R W McMurray
Journal:  J Rheumatol       Date:  1999-06       Impact factor: 4.666

2.  Clonal multicentric Castleman's disease with increased free Κ light chains in a patient with systemic lupus erythematosus.

Authors:  Matthijs Oyaert; Elke Boone; Liesbeth De Ceuninck; Els Moreau; Jo Van Dorpe; Hilde Vanpoucke; Dries Deeren
Journal:  Ann Hematol       Date:  2013-11-19       Impact factor: 3.673

3.  Association of Macrophage Activating Syndrome with Castleman's Syndrome in Systemic Lupus Erythematosus.

Authors:  Shamsa Shariatpanahi; Shahryar Pourfarzam; Mohammadhosein Gheini
Journal:  Iran J Pathol       Date:  2016

4.  Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.

Authors:  Ketna S Patel; Philip N Hawkins; Carol J Whelan; Julian D Gillmore
Journal:  BMJ Case Rep       Date:  2014-12-22

5.  Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.

Authors:  Ginevra De Marchi; Salvatore De Vita; Martina Fabris; Cathryn Ann Scott; Gianfranco Ferraccioli
Journal:  Haematologica       Date:  2004-04       Impact factor: 9.941

  5 in total
  2 in total

1.  A retrospective study of 44 patients with head and neck Castleman's disease.

Authors:  Taiqin Wang; Xiaoqiang Chen; Wei Chen; Liangwen Shi; Jianzhi Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-04       Impact factor: 2.503

2.  Chinese herbal compound prescription for systemic lupus erythematosus: A protocol for systematic review and meta-analysis.

Authors:  Yehao Luo; Donghan Xu; Yulei Fu; Xiusong Tang; Zhenfeng Chen; An Huang; Yuzhou Pang; Yunyan Zhang; Renfeng Li
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.